Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amason JD"'
Autor:
Burgess TL; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Amason JD; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America.; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Rubin JS; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Duveau DY; Division of Preclinical Innovation, National Center for Advancing Translational Studies, National Institutes of Health, Rockville, Maryland, United States of America., Lamy L; Division of Preclinical Innovation, National Center for Advancing Translational Studies, National Institutes of Health, Rockville, Maryland, United States of America., Roberts DD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Farrell CL; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Inglese J; Division of Preclinical Innovation, National Center for Advancing Translational Studies, National Institutes of Health, Rockville, Maryland, United States of America., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Studies, National Institutes of Health, Rockville, Maryland, United States of America., Miller TW; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America.; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Apr 02; Vol. 15 (4), pp. e0226661. Date of Electronic Publication: 2020 Apr 02 (Print Publication: 2020).
Autor:
Miller TW; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America.; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Amason JD; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America.; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Garcin ED; Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Catonsville, Maryland, United States of America., Lamy L; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America., Dranchak PK; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America., Macarthur R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America., Braisted J; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America., Rubin JS; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Burgess TL; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Farrell CL; Paradigm Shift Therapeutics LLC, Rockville, Maryland, United States of America., Roberts DD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Inglese J; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America.
Publikováno v:
PloS one [PLoS One] 2019 Jul 05; Vol. 14 (7), pp. e0218897. Date of Electronic Publication: 2019 Jul 05 (Print Publication: 2019).